152 related articles for article (PubMed ID: 38486456)
1. Engineer and split an efficient hypercompact CRISPR-CasΦ genome editor in plants.
Sun Y; Hu J; Hu Z; Zhou H; Gao Y; Liu Y; Ji Y; Xu G; Guo Y; Zhang Y; Tian Y; Liu X; Zhou S; Liu Y; Li T; Li C; Wan J
Plant Commun; 2024 Mar; ():100881. PubMed ID: 38486456
[No Abstract] [Full Text] [Related]
2. Genome editing in plants using the compact editor CasΦ.
Li Z; Zhong Z; Wu Z; Pausch P; Al-Shayeb B; Amerasekera J; Doudna JA; Jacobsen SE
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216822120. PubMed ID: 36652483
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-CasΦ from huge phages is a hypercompact genome editor.
Pausch P; Al-Shayeb B; Bisom-Rapp E; Tsuchida CA; Li Z; Cress BF; Knott GJ; Jacobsen SE; Banfield JF; Doudna JA
Science; 2020 Jul; 369(6501):333-337. PubMed ID: 32675376
[TBL] [Abstract][Full Text] [Related]
4. DNA interference states of the hypercompact CRISPR-CasΦ effector.
Pausch P; Soczek KM; Herbst DA; Tsuchida CA; Al-Shayeb B; Banfield JF; Nogales E; Doudna JA
Nat Struct Mol Biol; 2021 Aug; 28(8):652-661. PubMed ID: 34381246
[TBL] [Abstract][Full Text] [Related]
5. Hypercompact CRISPR-Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants.
Liu S; Sretenovic S; Fan T; Cheng Y; Li G; Qi A; Tang X; Xu Y; Guo W; Zhong Z; He Y; Liang Y; Han Q; Zheng X; Gu X; Qi Y; Zhang Y
Plant Commun; 2022 Nov; 3(6):100453. PubMed ID: 36127876
[No Abstract] [Full Text] [Related]
6. An Intein-Mediated Split-nCas9 System for Base Editing in Plants.
Yuan G; Lu H; De K; Hassan MM; Liu Y; Li Y; Muchero W; Abraham PE; Tuskan GA; Yang X
ACS Synth Biol; 2022 Jul; 11(7):2513-2517. PubMed ID: 35767601
[TBL] [Abstract][Full Text] [Related]
7. Geminiviral-induced genome editing using miniature CRISPR/Cas12j (CasΦ) and Cas12f variants in plants.
Gong Z; Previtera DA; Wang Y; Botella JR
Plant Cell Rep; 2024 Feb; 43(3):71. PubMed ID: 38372775
[No Abstract] [Full Text] [Related]
8. Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors.
Al-Shayeb B; Skopintsev P; Soczek KM; Stahl EC; Li Z; Groover E; Smock D; Eggers AR; Pausch P; Cress BF; Huang CJ; Staskawicz B; Savage DF; Jacobsen SE; Banfield JF; Doudna JA
Cell; 2022 Nov; 185(24):4574-4586.e16. PubMed ID: 36423580
[TBL] [Abstract][Full Text] [Related]
9. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus.
Kim DY; Lee JM; Moon SB; Chin HJ; Park S; Lim Y; Kim D; Koo T; Ko JH; Kim YS
Nat Biotechnol; 2022 Jan; 40(1):94-102. PubMed ID: 34475560
[TBL] [Abstract][Full Text] [Related]
10. Engineering Plants for Geminivirus Resistance with CRISPR/Cas9 System.
Zaidi SS; Mansoor S; Ali Z; Tashkandi M; Mahfouz MM
Trends Plant Sci; 2016 Apr; 21(4):279-281. PubMed ID: 26880316
[TBL] [Abstract][Full Text] [Related]
11. Potential Application of CRISPR/Cas9 System to Engineer Abiotic Stress Tolerance in Plants.
Ahmed T; Noman M; Shahid M; Muhammad S; Tahir Ul Qamar M; Ali MA; Maqsood A; Hafeez R; Ogunyemi SO; Li B
Protein Pept Lett; 2021; 28(8):861-877. PubMed ID: 33602066
[TBL] [Abstract][Full Text] [Related]
12. A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing.
Wang Y; Qi T; Liu J; Yang Y; Wang Z; Wang Y; Wang T; Li M; Li M; Lu D; Chang ACY; Yang L; Gao S; Wang Y; Lan F
Sci Adv; 2023 Feb; 9(6):eabo6405. PubMed ID: 36763662
[TBL] [Abstract][Full Text] [Related]
13. An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity.
Wu T; Liu C; Zou S; Lyu R; Yang B; Yan H; Zhao M; Tang W
Nat Chem Biol; 2023 Nov; 19(11):1384-1393. PubMed ID: 37400536
[TBL] [Abstract][Full Text] [Related]
14. Genome Editing in Plants: Exploration of Technological Advancements and Challenges.
Vats S; Kumawat S; Kumar V; Patil GB; Joshi T; Sonah H; Sharma TR; Deshmukh R
Cells; 2019 Nov; 8(11):. PubMed ID: 31689989
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient heritable targeted deletions of gene clusters and non-coding regulatory regions in Arabidopsis using CRISPR/Cas9.
Durr J; Papareddy R; Nakajima K; Gutierrez-Marcos J
Sci Rep; 2018 Mar; 8(1):4443. PubMed ID: 29535386
[TBL] [Abstract][Full Text] [Related]
16. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
Dey A; Nandy S
Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity.
Wu T; Liu C; Zou S; Lyu R; Yang B; Yan H; Zhao M; Tang W
Nat Chem Biol; 2024 Jan; 20(1):129. PubMed ID: 38040979
[No Abstract] [Full Text] [Related]
18. Genome-wide target specificity of CRISPR RNA-guided adenine base editors.
Kim D; Kim DE; Lee G; Cho SI; Kim JS
Nat Biotechnol; 2019 Apr; 37(4):430-435. PubMed ID: 30833658
[TBL] [Abstract][Full Text] [Related]
19. RNA-guided genome engineering: paradigm shift towards transposons.
Chang CW; Truong VA; Pham NN; Hu YC
Trends Biotechnol; 2024 Mar; ():. PubMed ID: 38443218
[TBL] [Abstract][Full Text] [Related]
20. Hypercompact TnpB and truncated TnpB systems enable efficient genome editing in vitro and in vivo.
Wang M; Sun Z; Liu Y; Yin P; Liang C; Tan L; Wei L; Wang Y; Yu H; Zhu Y; Hu X; Li N; Zhang R
Cell Discov; 2024 Mar; 10(1):31. PubMed ID: 38503726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
